Pfizer (PFE)

S&P 500 is Down 30%: You See Risk I See Opportunity! 

S&P 500 Introduction 2022 has been a bad year price-wise for the stock market as measured by the S&P 500. However, I contend that is not enough to simply know that the market is down, it is even more important to know why. Nevertheless, as you read this my guess would be that several thoughts …

25 Stocks Subscribers Asked To See | FAST Graphs

It’s a Market of Stocks – Not a Stock Market It would be an understatement to say that the stock market has been volatile recently. But as I always say, it’s a market of stocks, not a stock market. Much of the damage has resulted from stocks trading at significantly overvalued levels for several years. …

20 Dividend Growth Stocks A Rated Or Better Attractively Valued Blue-Chip

Introduction – 20 Dividend Stocks With this video I am presenting 20 A rated or better attractively valued dividend growth stocks with low debt and above-market yields.  I would like the viewer to think of these as research candidates.  In other words, in today’s overheated market I offer 20 extremely high-quality dividend growth stocks that …

Undervalued Growth and Dividend Growth in Health Technology: Part 11

Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.  With only a few minor exceptions, this is true for most companies, especially the pharmaceutical companies, operating in this sector. On the other hand, there are several examples …